Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
908.10
-8.15 (-0.89%) Natco Pharma informs about press release
Date: 22-05-2021Natco Pharma has informed that it has enclosed the Press Release on 22nd May 2021, titled ‘NATCO receives final approval for Everolimus tablets (generic for ZORTRESS) in the US market’.
The above information is a part of company’s filings submitted to BSE.